New Program Will Cap Medicare Monthly Co-Pays at $35 Today, the American Diabetes Association (ADA) joined the Centers for Medicare and Medicaid Services (CMS) for a White House event to announce the Part D Senior Savings Model, which will limit the cost of insulin for participating seniors to a maximum of $35 for a 30-day supply. “Together, we are helping 3.3 million seniors access insulin more affordably through significant caps on out-of-pocket co-pays,” said Tracey D. Brown, CEO of the American Diabetes Association. “The American Diabetes Association – the nation’s leading organization for
The American Diabetes Association (ADA) and Novo Nordisk, one of the world's leading companies in diabetes management and long-time supporter of the ADA, announce the transition of their 15-year signature 5K@ADA Run/Walk event to a virtual challenge. The 5K@ADA has been an official event during the Scientific Sessions for 15 years and has brought together over 13,400 participants. Through the continued support of Novo Nordisk, the 5K@ADA Virtual Challenge is free of charge to all participants. Everyone is encouraged to sign up , lace up and head out the door, right from their home over the
The American Diabetes Association (ADA) announces this year’s Professional Interest Group and Women’s Interprofessional Network Award recipients The American Diabetes Association® (ADA) is proud to announce the recipients of the 2020 Professional Interest Group and Women’s Interprofessional Network Awards. These awards, presented by various membership groups, recognize academics, health care providers and educators who have contributed to advances in specialized areas of diabetes care and research. Each recipient has shown outstanding commitment to achieving the vision of the ADA: life free of
Following the release of President Trump’s budget proposal for Fiscal Year 2021, Tracey D. Brown, Chief Executive Officer of the American Diabetes Association (ADA), issued the following statement: “Yesterday, the White House announced its FY2021 budget. While we were encouraged to see that the President recommended extending the highly successful Special Diabetes Program (SDP), we ask Congress to go further and provide a long-term renewal for SDP. In addition, far too many other public health and biomedical research programs would be subject to severe cuts under the President’s proposal
Strategic collaboration formed to raise awareness that all people with diabetes on blood glucose-lowering medications should have glucagon, preferable a ready-to-use formulation The American Diabetes Association ® (ADA) and Xeris Pharmaceuticals ® (Xeris BioPharma Holdings, Inc.), a national supporter of the ADA, are pleased to announce a multi-year strategic partnership to reinforce the importance of prescribing glucagon, preferably ready-to-use, for all individuals with diabetes who are treated with insulin and/or insulin secretagogues or those at high risk of hypoglycemia (low blood glucose
On April 3, 2025, North Dakota became the 27th state to pass a law to lower patient cost-sharing limits for insulin in state-regulated health insurance plans. In response to Governor Armstrong signing HB 1114, Matt Prokop, state government affairs director at the American Diabetes Association® (ADA), issued the following statement: “The American Diabetes Association commends North Dakota policymakers for the passage of HB 1114, which limits cost sharing for insulin and certain related supplies at $25 for a 30-day supply for those on state employee health insurance plans and state-regulated
It doesn’t matter whether you’ve been active in the past or not—you can still start now. But, if you have never been active or have not been active for a while, it is important to start slowly.
With your support, the American Diabetes Association® can continue our lifesaving work to make breakthroughs in research and provide people with the resources they need to fight diabetes.